Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii

被引:39
作者
Averbuch, D
Boekhout, T
Falk, R
Engelhard, D
Shapiro, M
Block, C
Polacheck, I
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Pediat, IL-91120 Jerusalem, Israel
[3] CBS Yeast Div, Utrecht, Netherlands
关键词
antifungal(s); Cryptococcus laurentii; cryptococcosis; fungemia;
D O I
10.1080/714031137
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report the recent isolation of Cryptococcus laurentii from the blood of a patient given the diagnosis of ganglioneuroblastoma. The organism was identified using physiological and molecular characteristics, including morphology, carbohydrate and nitrate assimilation, urease activity, inability to form melanin on appropriate media, positive staining with diazonium blue B and sequence analysis of the D1/D2 domain of 26S ribosomal DNA. The isolate was resistant to fluconazole and 5-fluorocytosine using both the Etest and a broth microdilution assay. Repeated recovery of the organism from different blood cultures, and the patient's good response to treatment with amphotericin B support its etiological role. C laurentii has rarely been implicated as a cause of clinically significant infections. The identity of reported isolates has not always been adequately documented, and some appear to have been isolated from lesions caused by Cryptococcus neoformans, emphasizing the true rarity of disease due to this fungus.
引用
收藏
页码:479 / 484
页数:6
相关论文
共 31 条
[1]   Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents [J].
Aller, AI ;
Martín-Mazuelos, E ;
Gutiérrez, MJ ;
Bernal, S ;
Chávez, N ;
Recio, FJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :997-1000
[2]  
Barnett J. A., 2000, CHARACTERISTICS IDEN
[3]  
Boekhout T., 1999, 4 INT C CRYPT CRYPT, P193
[4]  
Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, DOI DOI 10.1128/9781555818241
[5]   Cryptococcus laurentii fungemia in a premature neonate [J].
Cheng, MF ;
Chiou, CC ;
Liu, YC ;
Wang, HZ ;
Hsieh, KS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1608-1611
[6]  
CUSTIS PH, 1995, RETINA-J RET VIT DIS, V15, P300
[7]   PROGNOSTIC FACTORS IN CRYPTOCOCCAL MENINGITIS - STUDY IN 111 CASES [J].
DIAMOND, RD ;
BENNETT, JE .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :176-181
[8]   Multicenter comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms [J].
Espinel-Ingroff, A ;
Pfaller, M ;
Messer, SA ;
Knapp, CC ;
Killian, S ;
Norris, HA ;
Ghannoum, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) :591-595
[9]  
Fell J. W., 1998, P742
[10]   Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis [J].
Fell, JW ;
Boekhout, T ;
Fonseca, A ;
Scorzetti, G ;
Statzell-Tallman, A .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2000, 50 :1351-1371